Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sandra K. Malcolm"'
Publikováno v:
International Journal of Clinical Practice. 68:1130-1140
SUMMARY Objective: The safety and tolerability of three treatments for diabetic peripheral neuropathic pain (DPNP) were compared. Methods: A 12-week, randomized, open-label study confirming the non-inferiority of duloxetine (N = 138) vs. pregabalin (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b807bad58ea97edb69783036a21510b
https://doi.org/10.1111/ijcp.12452
https://doi.org/10.1111/ijcp.12452
Autor:
Michael J. Robinson, Sandra K. Malcolm, Jonna Ahl, Robert J. Tanenberg, R.C. Risser, Vladimir Skljarevski, Gordon Irving
Publikováno v:
Mayo Clinic Proceedings. 86:615-626
OBJECTIVE To determine whether duloxetine is noninferior to (as good as) pregabalin in the treatment of pain associated with diabetic peripheral neuropathy. PATIENTS AND METHODS We performed a 12-week, open-label study of patients with diabetic perip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e51f096422c148a7d75b2ee3d879e81
https://doi.org/10.4065/mcp.2010.0681
https://doi.org/10.4065/mcp.2010.0681
Publikováno v:
Pain practice : the official journal of World Institute of Pain. 14(8)
Background Patients with multiple sclerosis (MS) often report neuropathic pain (NP-MS). The purpose of this study was to assess the efficacy and tolerability of duloxetine as treatment for NP-MS. Methods In this study, 239 adults with NP-MS (duloxeti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be44556f7691d7670be7da1b9bb77730
https://pubmed.ncbi.nlm.nih.gov/24152240
https://pubmed.ncbi.nlm.nih.gov/24152240
Autor:
Albert J. Allen, Virginia K. Sutton, Humberto Quintana, Calvin R. Sumner, Kory Schuh, Douglas Kelsey, Jill Gonzales, Sandra K. Malcolm, Daniel L. Coury, Keith E. Saylor, Charles D. Casat
Publikováno v:
Pediatrics. 114(1)
Objectives. Atomoxetine seems to be as effective for treating attention-deficit/hyperactivity disorder (ADHD) when the daily dose is administered once in the morning as when the dose is divided and administered in the morning and evening. In the pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4a4aab7e18ba75239064b65c9c8cd18
https://pubmed.ncbi.nlm.nih.gov/15231966
https://pubmed.ncbi.nlm.nih.gov/15231966
Publikováno v:
The Journal of Pain. 12:P47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec8ea92d3d351b6ac8db1cbb69e90930
https://doi.org/10.1016/j.jpain.2011.02.190
https://doi.org/10.1016/j.jpain.2011.02.190
Publikováno v:
The Journal of Pain. 9:22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9978c2c5b8516869f12201f3f8de9f9
https://doi.org/10.1016/j.jpain.2008.01.106
https://doi.org/10.1016/j.jpain.2008.01.106
Publikováno v:
Psychoneuroendocrinology. 25:S62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e023aff2c63dbdcd26759edb92f93e4
https://doi.org/10.1016/s0306-4530(00)90181-1
https://doi.org/10.1016/s0306-4530(00)90181-1
Autor:
Rosalie J. Bakken, Martin Paczkowski, Hal P. Kramer, Alan A. Axelson, David W. Williams, Sandra K. Malcolm, Calvin R. Sumner, Douglas K. Kelsey
Publikováno v:
Current Medical Research & Opinion; Feb2008, Vol. 24 Issue 2, p449-460, 12p